Terms: = Breast cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1
375 results:
1. Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human breast cancer.
Wescott EC; Sun X; Gonzalez-Ericsson P; Hanna A; Taylor BC; Sanchez V; Bronzini J; Opalenik SR; Sanders ME; Wulfkuhle J; Gallagher RI; Gomez H; Isaacs C; Bharti V; Wilson JT; Ballinger TJ; Santa-Maria CA; Shah PD; Dees EC; Lehmann BD; Abramson VG; Hirst GL; Brown Swigart L; van ˈt Veer LJ; Esserman LJ; Petricoin EF; Pietenpol JA; Balko JM
Cancer Res Commun; 2024 Apr; 4(4):1120-1134. PubMed ID: 38687247
[TBL] [Abstract] [Full Text] [Related]
2. Anticancer, antioxidant, and antibacterial activity of chemically fingerprinted extract from Cyclamen persicum Mill.
Al-Rimawi F; Khalid M; Salah Z; Zawahreh MAA; Alnasser SM; Alshammari SO; Wedian F; Karimulla S; Almutairi A; Alanazi FIB; Alanazi HO; Al-Mazaideh GM; Nafidi HA; Salamatullah AM; Mekonnen AB; Bourhia M
Sci Rep; 2024 Apr; 14(1):8488. PubMed ID: 38605145
[TBL] [Abstract] [Full Text] [Related]
3. Impact of Histone Lysine Methyltransferase SUV4-20H2 on cancer Onset and Progression with Therapeutic Potential.
Papadaki S; Piperi C
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473745
[TBL] [Abstract] [Full Text] [Related]
4. Dual-microRNA-Controlled Electrochemiluminescence Biosensor for breast cancer Diagnosis and Supplemental Identification of breast cancer Metastasis.
Ye Z; Ma M; Chen Y; Liu R; Zhang Y; Ma P; Song D
Anal Chem; 2024 Feb; 96(8):3636-3644. PubMed ID: 38357821
[TBL] [Abstract] [Full Text] [Related]
5. AKR1C3 silencing inhibits autophagy-dependent glycolysis in thyroid cancer cells by inactivating ERK signaling.
Gao Y; Tao W; Wang S; Duan R; Zhang Z
Drug Dev Res; 2024 Feb; 85(1):e22142. PubMed ID: 38349266
[TBL] [Abstract] [Full Text] [Related]
6. In-vitro Antioxidant Activity and Flow Cytometric Analysis of Simarouba glauca DC Bark Extract Induced Apoptosis in Triple Negative breast cancer Cells.
Pandhari RMR; Taranath TC
Asian Pac J Cancer Prev; 2024 Jan; 25(1):201-210. PubMed ID: 38285785
[TBL] [Abstract] [Full Text] [Related]
7. Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation.
Sinha S; Paul S; Acharya SS; Das C; Dash SR; Bhal S; Pradhan R; Das B; Kundu CN
Med Oncol; 2024 Jan; 41(2):49. PubMed ID: 38184505
[TBL] [Abstract] [Full Text] [Related]
8. Oxidized ATM governs stemness of breast cancer stem cell through regulating ubiquitylation and acetylation switch.
Zhou X; Liu X; Wan X; Xu M; Wang R; Yang D; Peng M; Jin T; Tang R; Liu M; Hou Y
Biochem Biophys Res Commun; 2024 Jan; 691():149243. PubMed ID: 38016338
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Prognostic Relevance.
Siqueira JM; Mitani Y; Hoff CO; Bonini F; Guimaraes de Sousa L; Marques-Piubelli ML; Purushothaman A; Mitani M; Dai H; Lin SY; Spiotto MT; Hanna EY; McGrail DJ; El-Naggar AK; Ferrarotto R
Mod Pathol; 2024 Jan; 37(1):100371. PubMed ID: 38015043
[TBL] [Abstract] [Full Text] [Related]
10. A SOX9-B7x axis safeguards dedifferentiated tumor cells from immune surveillance to drive breast cancer progression.
Liu Y; John P; Nishitani K; Cui J; Nishimura CD; Christin JR; Couturier N; Ren X; Wei Y; Pulanco MC; Galbo PM; Zhang X; Fu W; Cui W; Bartholdy BA; Zheng D; Lauvau G; Fineberg SA; Oktay MH; Zang X; Guo W
Dev Cell; 2023 Dec; 58(23):2700-2717.e12. PubMed ID: 37963469
[TBL] [Abstract] [Full Text] [Related]
11. A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant cancers with B7-H4 Expression.
Gitto SB; Whicker M; Davies G; Kumar S; Kinneer K; Xu H; Lewis A; Mamidi S; Medvedev S; Kim H; Anderton J; Tang EJ; Ferman B; Coats S; Wilkinson RW; Brown E; Powell DJ; Simpkins F
Clin Cancer Res; 2024 Apr; 30(8):1567-1581. PubMed ID: 37882675
[TBL] [Abstract] [Full Text] [Related]
12. An Investigation of the Effects of
Jin YC; Dong LJ; Yang QY; Xiong WN; Wang WY; Feng XH; Yu W; Huang W; Chen BF
Biomed Environ Sci; 2023 Sep; 36(9):814-825. PubMed ID: 37803894
[TBL] [Abstract] [Full Text] [Related]
13. The loss of B7-H4 expression in breast cancer cells escaping from T cell cytotoxicity contributes to epithelial-to-mesenchymal transition.
Zhou L; Wu J; Ruan M; Xiao Y; Lan H; Wu Q; Yu CW; Zhang Q
Breast Cancer Res; 2023 Oct; 25(1):115. PubMed ID: 37794509
[TBL] [Abstract] [Full Text] [Related]
14. SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models.
Gray E; Ulrich M; Epp A; Younan P; Sahetya D; Hensley K; Allred S; Huang LY; Hahn J; Gahnberg K; Treuting PM; Trueblood ES; Gosink JJ; Thurman R; Wo S; Spahr K; Haass EJ; Snead K; Miller D; Padilla M; Smith AJ; Frantz C; Schrum JP; Nazarenko N; Gardai SJ
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37793853
[TBL] [Abstract] [Full Text] [Related]
15. Circular RNA eukaryotic translation initiation factor 6 facilitates tpc-1 cell proliferation and invasion through the microRNA-138-5p/lipase H axis.
Yi D; Zhang D; Zeng Z; Zhang S; Song B; He C; Li M; He J
Funct Integr Genomics; 2023 Sep; 23(4):313. PubMed ID: 37776372
[TBL] [Abstract] [Full Text] [Related]
16. Reducing hospital admissions in patients with malignant pleural effusion: a quality improvement study.
Cloyes RR; Josan E; Pastis N; Ma J; Palettas M; Peng J; Vasko-Wood S; Mohrman C; Ghattas C; Presley C; Revelo A; Pannu J
BMJ Open Qual; 2023 Sep; 12(3):. PubMed ID: 37751941
[TBL] [Abstract] [Full Text] [Related]
17. Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes.
Sanuki F; Mikami Y; Nishimura H; Fujita Y; Monobe Y; Nomura T; Taira N; Moriya T
Breast Cancer; 2023 Nov; 30(6):1041-1053. PubMed ID: 37642903
[TBL] [Abstract] [Full Text] [Related]
18. Reveal the potential molecular mechanism of circRNA regulating immune-related mRNA through sponge miRNA in the occurrence and immune regulation of papillary thyroid cancer.
Wang B; Shen W; Yan L; Li X; Zhang L; Zhao S; Jin X
Ann Med; 2023; 55(2):2244515. PubMed ID: 37603701
[TBL] [Abstract] [Full Text] [Related]
19. A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy.
Zambelli A; Cazzaniga M; La Verde N; Munzone E; Antonazzo IC; Mantovani LG; Di Cosimo S; Mancuso A; Generali D; Cortesi PA
Breast; 2023 Oct; 71():113-121. PubMed ID: 37573652
[TBL] [Abstract] [Full Text] [Related]
20. Platinum(IV)-Gold(I) Agents with Promising Anticancer Activity: Selected Studies in 2D and 3D Triple-Negative breast cancer Models.
López-Hernández JE; Nayeem N; Cerón-Carrasco JP; Ahad A; Hafeez A; León IE; Contel M
Chemistry; 2023 Oct; 29(59):e202302045. PubMed ID: 37507346
[TBL] [Abstract] [Full Text] [Related]
[Next]
